Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study.

BMC cancer - 31 May 2024

Li Jinshuai, Yang Zixian, Wang Tao, Li Mengqi, Wu Xiangjian, Fu Xiaoyan, Yang Chunfeng, Li Yangpu, Wang Ximing, Lan Zhiming, Li Minfang, Chen Sheng

Abstract excerpt

BACKGROUND: The causal impact of lipid-lowering drugs on ovarian cancer (OC) and cervical cancer (CC) has received considerable attention, but its causal relationship is still a subject of debate. Hence, the objective of this study is to evaluate the impact of lipid-lowering medications on the occurrence risk of OC and CC through Mendelian randomization (MR) analysis of drug targets. METHODS: This investigation...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genome-Wide Association Study
Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hydroxymethylglutaryl CoA Reductases

Share to Hypolipidemic Agents

Share to Mendelian Randomization Analysis

Share to Ovarian Neoplasms

Share to Proprotein Convertase 9

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 38822303
DOI: 10.1186/s12885-024-12434-z
PMCID: PMC11143665

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study.PMID 38822303Read ↗

Causal association between lipid-lowering drugs and cancers: A drug target Mendelian randomization study.Semantic proximity Read ↗

Lipids, lipid-modifying drug Target genes and Bladder cancer: a Mendelian randomization studySemantic proximity Read ↗

Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancersSemantic proximity Read ↗

Genetic association of lipids and lipid-lowering drug target genes with Endometrial carcinoma: a drug target Mendelian randomization study.Semantic proximity Read ↗

Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancersSemantic proximity Read ↗

Lipids, lipid-modified drug target genes, and the risk of male infertility: a Mendelian randomization study.Semantic proximity Read ↗

Causal effects of lipid-lowering therapies on aging-related outcomes and risk of cancers: a drug-target Mendelian randomization study.Semantic proximity Read ↗

Review of Mendelian Randomization Studies on Ovarian CancerSemantic proximity Read ↗

Association of lipid-lowering drugs with COVID-19 outcomes: A Mendelian Randomization studySemantic proximity Read ↗

Causal association between 637 human metabolites and ovarian cancer: a mendelian randomization studySemantic proximity Read ↗

Causal relationship between lipid-lowering drugs and ocular disorders: A drug-targeted Mendelian randomization studySemantic proximity Read ↗

Associations of blood lipids and LDL cholesterol lowering drug-targets with colorectal cancer risk: a Mendelian randomisation study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.